Skip to Content


Office of the Director, National Institutes of Health; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee on Research on Women's Health.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Advisory Committee on Research on Women's Health.

Date: September 24, 2014.

Time: 8:00 a.m. to 4:00 p.m.

Agenda: The Committee serves to advise and make recommendations to the Director, Office of Research on Women's Health (ORWH) on a broad range of topics including, the current scope of research on women's health and the influence of sex and gender on human health, efforts to understand the issues related to women in biomedical careers and their needs, and the current status of inclusion of women in clinical trials research.

Place: National Institutes of Health, Building 31, Room 6C, 31 Center Drive, Bethesda, MD 20892.

Contact Person: Susan E. Maier, Ph.D., Executive Secretary, NIH/OD/ORWH, 6707 Democracy Blvd., Room 400, Bethesda, MD 20852, 301-435-1573,

Any interested person may file written comments for the public record by submitting their comments at the following address: Written comments only for the public record must not exceed two single-spaced, typed pages, using a 12-point typeface and 1 inch margins; it is preferred that the document be prepared in the MS Word® format. There will be an opportunity for public comments at the meeting. Written comments for those that would like to speak must still be presented prior to the meeting date. Each presenter will have a maximum of 5 minutes to present orally. The length of the comment period is restricted to 30 minutes which will allow for no more than 6 speakers. Speaker openings will be granted on a first come, first serve basis. Upon arrival at the meeting those that wish to speak and have previously submitted written comment may sign the special roster for speakers. Speakers on the special roster will speak in the order in which they sign in. There may not be time for all to speak. Public comments will be heard at the end of the meeting. Only testimony submitted to this email address and received in advance of the meeting are part of the official meeting record.

Supplementary Information: A draft agenda for this meeting is posted at​about/​acrwh/​index.asp. The meeting will be live-video streamed at​.

Individuals who plan to attend the meeting in person are reminded that NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Start Signature

Dated: August 14, 2014.

Carolyn Baum,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2014-19682 Filed 8-19-14; 8:45 am]